Lansoprazole Delayed-release Orally Disintegrating Tablets 15 mg Bottle Label (Image 01)
Lansoprazole Tablet, Orally Disintegrating, Delayed Release
Product Images NDC 0378-6982
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 0378-6982). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Lansoprazole Delayed-release Orally Disintegrating Tablets 30 mg Bottle Label (Image 02)
Lansoprazole Structural Formula (Image 03)
Figure 1. (Image 04)
The text provides a table showing the mean severity of day heartburn for evaluable patients, categorized into four levels: severe, moderate, mild, and none. The severity levels are denoted by numerals 3, 2, 1, and 0 respectively. Two drugs, Lansoprazole 15mg and Lansoprazole 30mg, are mentioned as having been administered to the patients. There is no other information available to provide further context.*
Figure 2. (Image 05)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
